Related Experiment Video
Updated: Jun 19, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Comparative in-vitro activity of cefsulodin and ceftazidime against ticarcillin-resistant Pseudomonas aeruginosa
1C.H.U. Cochin, Service de Bactériologie 75674-Paris Cedex 14, France.
Abstract:
The in-vitro antibacterial activity of ceftazidime was compared with that of cefsulodin and ticarcillin against 140 strains of Pseudomonas aeruginosa. Against 123 clinical isolates, geometric mean MICs were 1499mg/l for ticarcillin, 15 mg/l for cefsulodin and 2.1 mg/l for ceftazidime. Against constitutive beta-lactamase producers (93 strains), and according to the type of enzyme (TEM-1, carbenicillinases, oxacillinases), ceftazidime had similar activity but MICs of cefsulodin were particularly affected by highly ticarcillin-resistant (carbenicillinase pIs 53, 5.7 and 575) strains. Against ticarcillin-resistant (constitutive beta-lactamase non-producers) and ticarcillin-susceptible strains, the MICs of ceftazidime were slightly lower than those of cefsulodin.
More Related Videos
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
07:16Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance